Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tea Nieminen, Helena Käyhty & Anu Kantele. (1996) Circulating Antibody Secreting Cells and Humoral Antibody Response after Parenteral Immunization with a Meningococcal Polysaccharide Vaccine. Scandinavian Journal of Infectious Diseases 28:1, pages 53-58.
Read now
Read now
Mustafa Abdalla M. Salih, Hassan Sid Ahmed, Zein A. Karrar, Izzeldin Kamil, Khalid A. Osman, Helena Palmgren, Yngve Hofvander & Per Olcén. (1990) Features of a Large Epidemic of Group A Meningococcal Meningitis in Khartoum, Sudan in 1988. Scandinavian Journal of Infectious Diseases 22:2, pages 161-170.
Read now
Read now
Mustafa Abdalla M. Salih. (1989) Childhood Acute Bacterial Meningitis in the Suda: An Epidemiological, Clinical and Laboratory Study. Scandinavian Journal of Infectious Diseases 21:sup66, pages 1-103.
Read now
Read now
John E. Sippel & Carl E. Frasch. (1981) Meningococci. CRC Critical Reviews in Microbiology 8:3, pages 267-302.
Read now
Read now
Articles from other publishers (30)
N. N. Kostyukova & V. A. Bekhalo. (2016) Current Meningococcal Vaccines: Advantages and Disadvantages and New Challenges. Epidemiology and Vaccine Prevention 15:4, pages 64-73.
Crossref
Crossref
Dace V. Madore, Bruce D. Meade, Fran Rubin, Carolyn Deal & Freyja Lynn. (2010) Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads. Vaccine 28:29, pages 4539-4547.
Crossref
Crossref
JURIS ALLUNANS, KNUT IVAN KRISTIANSEN, REZA ASSALKHOU & MAGNAR BJØRÅS. (2008)
Bacteriocins (meningocins) in Norwegian isolates of
Neisseria meningitidis:
possible role in the course of a meningococcal epidemic
. APMIS 116:5, pages 333-344.
Crossref
Crossref
P. Domingo & N. Barquet. 2007. Infectious Diseases in Critical Care. Infectious Diseases in Critical Care
341
371
.
Hani Jokhdar, Ray Borrow, Abdulrazaq Sultan, Mousaed Adi, Christine Riley, Emily Fuller & David Baxter. (2004) Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia. Clinical and Vaccine Immunology 11:1, pages 83-88.
Crossref
Crossref
Pere Domingo & Nicolau Barquet. 2001. Critical Care Infectious Diseases Textbook. Critical Care Infectious Diseases Textbook
473
502
.
JOHN B. ROBBINS, RACHEL SCHNEERSON & EMIL C. GOTSCHLICH. (2000) A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine. The Pediatric Infectious Disease Journal 19:10, pages 945-953.
Crossref
Crossref
John B Robbins, David W Towne, Emil C Gotschlich & Rachel Schneerson. (1997) “Love's labours lost”: failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. The Lancet 350:9081, pages 880-882.
Crossref
Crossref
P. Kriz, J. Vlckova & M. Bobak. (2009) Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic. Epidemiology and Infection 115:3, pages 411-418.
Crossref
Crossref
J.Y. Riou, M. Guibourdenche, B. Hubert, J. Perrin, M.P. Le Pennec, J.M.P. Lafaye, A. Le Faou, E. Denamur, L. Berardi, J. Freney, M. Chomarat, G. Barbe, M.J. Sanson Le Pors, A. Sedallian & C. Krembel. (1989) Infections a Neisseria meningitidis du serogroupe a en France (aout 1987 ? mars 1988). Relations avec l'epidemie de la mecque d'aout 1987. M?decine et Maladies Infectieuses 19:5, pages 305-314.
Crossref
Crossref
J J KimR E MandrellZ HuM A WesterinkJ T PoolmanJ M Griffiss. (1988) Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidis. Infection and Immunity 56:10, pages 2631-2638.
Crossref
Crossref
R.G. Masterton, E.R. Youngs, J.C.R. Wardle, K.F. Croft & D.M. Jones. (1988) Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine. Journal of Infection 17:2, pages 177-182.
Crossref
Crossref
J M Griffiss, J P O'Brien, R Yamasaki, G D Williams, P A Rice & H Schneider. (1987) Physical heterogeneity of neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression. Infection and Immunity 55:8, pages 1792-1800.
Crossref
Crossref
R J Sugasawara. (1985) Recognition of serogroup A Neisseria meningitidis serotype antigens by human antisera. Infection and Immunity 48:1, pages 23-28.
Crossref
Crossref
Bolan Gail & Barza Michael. (1985) Acute Bacterial Meningitis in Children and Adults: A Perspective. Medical Clinics of North America 69:2, pages 231-241.
Crossref
Crossref
I. Mohammed, E.N. Obineche, G.C. Onyemelukwe & K. Zaruba. (1984) Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria. Journal of Infection 9:2, pages 190-196.
Crossref
Crossref
Pavla Kuzemenska, Bohumir Kriz & Eva Svandova. (1984) Meningococcal Meningitis in CSR: A Preepidemic Situation?. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale. A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie 257:1, pages 195-203.
Crossref
Crossref
Heikki Peltola, J Matti Kataja & P.Helena Mäkelä. (1982) SHIFT IN THE AGE-DISTRIBUTION OF MENINGOCOCCAL DISEASE AS PREDICTOR OF AN EPIDEMIC?. The Lancet 320:8298, pages 595-597.
Crossref
Crossref
Nancy Binkin & Jeffrey Band. (1982) EPIDEMIC OF MENINGOCOCCAL MENINGITIS IN BAMAKO, MALI: EPIDEMIOLOGICAL FEATURES AND ANALYSIS OF VACCINE EFFICACY. The Lancet 320:8293, pages 315-318.
Crossref
Crossref
HELENA KÄYHTY. (2007)
The unspecific antibody response to
N. meningitidis
group A capsular polysaccharide often seen in bacteraemic diseases
. Parasite Immunology 4:3, pages 157-170.
Crossref
Crossref
Aulikki Sivonen. (1981) Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates. Journal of Infection 3:3, pages 266-272.
Crossref
Crossref
Idris Mohammed & Karel Zaruba. (1981) CONTROL OF EPIDEMIC MENINGOCOCCAL MENINGITIS BY MASS VACCINATION. The Lancet 318:8237, pages 80-83.
Crossref
Crossref
H Käyhty. (1980) Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine. Journal of Clinical Microbiology 12:2, pages 256-263.
Crossref
Crossref
Heikki Peltola. (1980) Indications for use of meningococcal vaccine. The Journal of Pediatrics 97:2, pages 330-331.
Crossref
Crossref
B.M Greenwood & S.S Wali. (1980) CONTROL OF MENINGOCOCCAL INFECTION IN THE AFRICAN MENINGITIS BELT BY SELECTIVE VACCINATION. The Lancet 315:8171, pages 729-732.
Crossref
Crossref
B.M. Greenwood, H.C. Whittle, A.K. Bradley, M.T. Fayet & H.M. Gilles. (1980) The duration of the antibody response to meningococcal vaccination in an African village. Transactions of the Royal Society of Tropical Medicine and Hygiene 74:6, pages 756-760.
Crossref
Crossref
B.M. Greenwood, A.K. Bradley, I.S. Blakebrough, H.C. Whittle, T.F. de C. Marshall & H.M. Gilles. (1980) The immune response to a meningococcal polysaccharide vaccine in an African village. Transactions of the Royal Society of Tropical Medicine and Hygiene 74:3, pages 340-346.
Crossref
Crossref
. (1978) Who Should be Given Meningococcal Vaccine?. The Lancet 312:8101, pages 1185-1186.
Crossref
Crossref
P.Helena M?kel?Heikki Peltola. (1978) GROUP-SPECIFIC MENINGOCOCCAL VACCINATION AND EPIDEMICS CAUSED BY OTHER GROUPS OF MENINGOCOCCI. The Lancet 312:8093, pages 780-781.
Crossref
Crossref
Jukka Nikoskelainen, Esa Lähtönen, Aila Leino, J. Lennart Kalliomäki & Auli Toivanen. (1978) IS GROUP-SPECIFIC MENINGOCOCCAL VACCINATION RESULTING IN EPIDEMICS CAUSED BY OTHER GROUPS OF VIRULENT MENINGOCOCCI?. The Lancet 312:8086, pages 403-405.
Crossref
Crossref